SKI Market

Indian Indices

Nifty

24,578.35 -346.35
(-1.39%)

Sensex

81,148.22 -1,281.68
( -1.55%)

Bank Nifty

54,940.85 -442.00
( -0.80%)

Nifty IT

37,354.60 -927.95
( -2.42%)

Global Indices

Nasdaq

42,424.12 1,153.74
(2.80%)

Dow Jones

5,865.06 184.15
(3.24%)

Hang Seng

38,283.51 639.25
(1.70%)

Nikkei 225

8,602.92 -2.06
(-0.02%)

Forex

USD-INR

85.41 0.03
(0.03%)

EUR-INR

96.03 -0.26
(-0.27%)

GBP-INR

113.57 0.08
(0.07%)

JPY-INR

0.59 0.00
(-0.40%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Unjha Formulations Ltd

Industry : Pharmaceuticals - Indian - Formulations

BSE Code

ISIN Demat

Book Value()

531762

INE576D01015

7.4085482

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

N.A

16.22

10.32

EPS(TTM)

Face Value()

Div & Yield %

1.42

Back

IFL Enterprises reports consolidated net loss of Rs 0.42 crore in the September 2024 quarter

Nov 14,2024

Net loss of IFL Enterprises reported to Rs 0.42 crore in the quarter ended September 2024 as against net profit of Rs 0.31 crore during the previous quarter ended September 2023. Sales rose 54.30% to Rs 2.87 crore in the quarter ended September 2024 as against Rs 1.86 crore during the previous quarter ended September 2023.

Particulars	Quarter Ended
	Sep. 2024	Sep. 2023	% Var.
Sales	2.87	1.86	54
OPM %	-9.06	4.30	-
PBDT	-0.41	0.43	PL
PBT	-0.57	0.41	PL
NP	-0.42	0.31	PL

24,578.35 -346.35 (-1.39%)

81,148.22 -1,281.68 ( -1.55%)

54,940.85 -442.00 ( -0.80%)

37,354.60 -927.95 ( -2.42%)

42,424.12 1,153.74 (2.80%)

5,865.06 184.15 (3.24%)

38,283.51 639.25 (1.70%)

8,602.92 -2.06 (-0.02%)

85.41 0.03 (0.03%)

96.03 -0.26 (-0.27%)

113.57 0.08 (0.07%)

0.59 0.00 (-0.40%)